Integra LifeSciences Parts Ways With CEO Poul; Essig Retakes Reins

Dow Jones

05/05

By Colin Kellaher

Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job.

Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO.

Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010.

The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board.

Integra said it doesn't plan to initiate a search for a new CEO.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

May 05, 2026 06:49 ET (10:49 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2633491197"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2633491197\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2633491197?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-05 18:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2633491197","market":"other","top_or_hot":-1,"title":"Integra LifeSciences Parts Ways With CEO Poul; Essig Retakes Reins","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job. \n</p>\n<p>\n  Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO. \n</p>\n<p>\n  Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010. \n</p>\n<p>\n  The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board. \n</p>\n<p>\n  Integra said it doesn't plan to initiate a search for a new CEO. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 05, 2026 06:49 ET (10:49 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Integra LifeSciences Parts Ways With CEO Poul; Essig Retakes Reins</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntegra LifeSciences Parts Ways With CEO Poul; Essig Retakes Reins\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-05 18:49</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job. \n</p>\n<p>\n  Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO. \n</p>\n<p>\n  Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010. \n</p>\n<p>\n  The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board. \n</p>\n<p>\n  Integra said it doesn't plan to initiate a search for a new CEO. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 05, 2026 06:49 ET (10:49 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2633491197","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2633491197","pubTimestamp":1777978140,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job.Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO.Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010.The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board.Integra said it doesn't plan to initiate a search for a new CEO.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","IART":"英特格拉生命科学"},"translate_title":"Integra LifeSciences与首席执行官Poul分道扬镳；醋夺回缰绳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IART":0.9},"content_text":"By Colin Kellaher \n\n\n \n\n\n  Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job. \n\n\n  Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO. \n\n\n  Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010. \n\n\n  The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board. \n\n\n  Integra said it doesn't plan to initiate a search for a new CEO. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2026 06:49 ET (10:49 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}